You are here: Home » PTI Stories » National » News
Business Standard

IIL launches vaccine to combat tapeworm in pigs

Press Trust of India  |  New Delhi 

NDDB's arm Indian Immunologicals Ltd (IIL) today announced the launch of Cysvax vaccine to fight against tapeworms in pigs and this may also help reduce incidence of epilepsy in human beings.

Indian Immunologicals Ltd was set up by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price.



"IIL has developed a recombinant porcine (pigs) cysticercosis vaccine - Cysvax for use in pigs which also has the potential to significantly reduce the incidence of epilepsy in humans," the company said in a statement.

Vaccination of pigs can break the tapeworm parasite's life-cycle and enable in removing the source of infection for humans, it added.

IIL claimed that Cysvax is the world's first vaccine to fight against Tapeworms in pigs.

Commenting on the development, Indian Immunologicals Ltd Managing Director K Anand Kumar said: "In line with WHO's 'One Health' (Health of humans, animals and ecosystems are interconnected) Cysvax will significantly reduce the incidence of epilepsy in the developing world."

IIL collaborated with Dr Marshall Lightowlers, University of Melbourne, Australia and GALVmed (Global Alliance for Veterinary medicine) to develop this vaccine, the company said.

It obtained license the to manufacture and market this product after conducting extensive field trials in India and many other countries such as Spain, Peru etc, it added.
(Reopens DCM85)

WHO has designated cysticercosis as one of the 17 "neglected tropical diseases" worldwide. The life cycle of a tapeworm is dependent on the link between humans and pigs.

Any interruption in this link can result in the elimination of the parasite. Vaccination of pigs can break the parasite's life-cycle and enable in removing the source of infection for humans, the city-based IIL said.

Open defecation and unhygienic pig rearing are the primary breeding grounds for tapeworms. Cases of cysticercosis have been found to occur across India, particularly in north Uttar Pradesh and Northeast states.

Prevalence of porcine cysticercosis, as reported from slaughterhouse data, ranges from 7 per cent to 12 per cent in all pigs, according to the company, one of the largest animal and human health players in India.

RECOMMENDED FOR YOU

IIL launches vaccine to combat tapeworm in pigs

NDDB's arm Indian Immunologicals Ltd (IIL) today announced the launch of Cysvax vaccine to fight against tapeworms in pigs and this may also help reduce incidence of epilepsy in human beings. Indian Immunologicals Ltd was set up by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. "IIL has developed a recombinant porcine (pigs) cysticercosis vaccine - Cysvax for use in pigs which also has the potential to significantly reduce the incidence of epilepsy in humans," the company said in a statement. Vaccination of pigs can break the tapeworm parasite's life-cycle and enable in removing the source of infection for humans, it added. IIL claimed that Cysvax is the world's first vaccine to fight against Tapeworms in pigs. Commenting on the development, Indian Immunologicals Ltd Managing Director K Anand Kumar said: "In line with WHO's 'One Health' (Health NDDB's arm Indian Immunologicals Ltd (IIL) today announced the launch of Cysvax vaccine to fight against tapeworms in pigs and this may also help reduce incidence of epilepsy in human beings.

Indian Immunologicals Ltd was set up by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price.

"IIL has developed a recombinant porcine (pigs) cysticercosis vaccine - Cysvax for use in pigs which also has the potential to significantly reduce the incidence of epilepsy in humans," the company said in a statement.

Vaccination of pigs can break the tapeworm parasite's life-cycle and enable in removing the source of infection for humans, it added.

IIL claimed that Cysvax is the world's first vaccine to fight against Tapeworms in pigs.

Commenting on the development, Indian Immunologicals Ltd Managing Director K Anand Kumar said: "In line with WHO's 'One Health' (Health of humans, animals and ecosystems are interconnected) Cysvax will significantly reduce the incidence of epilepsy in the developing world."

IIL collaborated with Dr Marshall Lightowlers, University of Melbourne, Australia and GALVmed (Global Alliance for Veterinary medicine) to develop this vaccine, the company said.

It obtained license the to manufacture and market this product after conducting extensive field trials in India and many other countries such as Spain, Peru etc, it added.
(Reopens DCM85)

WHO has designated cysticercosis as one of the 17 "neglected tropical diseases" worldwide. The life cycle of a tapeworm is dependent on the link between humans and pigs.

Any interruption in this link can result in the elimination of the parasite. Vaccination of pigs can break the parasite's life-cycle and enable in removing the source of infection for humans, the city-based IIL said.

Open defecation and unhygienic pig rearing are the primary breeding grounds for tapeworms. Cases of cysticercosis have been found to occur across India, particularly in north Uttar Pradesh and Northeast states.

Prevalence of porcine cysticercosis, as reported from slaughterhouse data, ranges from 7 per cent to 12 per cent in all pigs, according to the company, one of the largest animal and human health players in India.
image
Business Standard
177 22

IIL launches vaccine to combat tapeworm in pigs

NDDB's arm Indian Immunologicals Ltd (IIL) today announced the launch of Cysvax vaccine to fight against tapeworms in pigs and this may also help reduce incidence of epilepsy in human beings.

Indian Immunologicals Ltd was set up by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price.

"IIL has developed a recombinant porcine (pigs) cysticercosis vaccine - Cysvax for use in pigs which also has the potential to significantly reduce the incidence of epilepsy in humans," the company said in a statement.

Vaccination of pigs can break the tapeworm parasite's life-cycle and enable in removing the source of infection for humans, it added.

IIL claimed that Cysvax is the world's first vaccine to fight against Tapeworms in pigs.

Commenting on the development, Indian Immunologicals Ltd Managing Director K Anand Kumar said: "In line with WHO's 'One Health' (Health of humans, animals and ecosystems are interconnected) Cysvax will significantly reduce the incidence of epilepsy in the developing world."

IIL collaborated with Dr Marshall Lightowlers, University of Melbourne, Australia and GALVmed (Global Alliance for Veterinary medicine) to develop this vaccine, the company said.

It obtained license the to manufacture and market this product after conducting extensive field trials in India and many other countries such as Spain, Peru etc, it added.
(Reopens DCM85)

WHO has designated cysticercosis as one of the 17 "neglected tropical diseases" worldwide. The life cycle of a tapeworm is dependent on the link between humans and pigs.

Any interruption in this link can result in the elimination of the parasite. Vaccination of pigs can break the parasite's life-cycle and enable in removing the source of infection for humans, the city-based IIL said.

Open defecation and unhygienic pig rearing are the primary breeding grounds for tapeworms. Cases of cysticercosis have been found to occur across India, particularly in north Uttar Pradesh and Northeast states.

Prevalence of porcine cysticercosis, as reported from slaughterhouse data, ranges from 7 per cent to 12 per cent in all pigs, according to the company, one of the largest animal and human health players in India.

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard